Biofrontera Inc. (BFRI)
Biofrontera Inc. (BFRI)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,317 | 6,392 | 3,417 | 7,239 |
| Investment, related party | 9 | 9 | 10 | 9 |
| Accounts receivable, net | 3,879 | 7,291 | 2,995 | 3,955 |
| Inventories | 1,231 | 1,426 | 4,329 | 4,028 |
| Asset held for sale | NaN | NaN | 2,300 | 2,300 |
| Prepaid expenses and other current assets | 1,062 | 2,279 | 629 | 331 |
| Other assets, related party | 661 | 686 | 733 | 953 |
| Total current assets | 13,159 | 18,083 | 14,413 | 18,815 |
| Inventories, long term | 3,591 | 3,729 | NaN | NaN |
| Property and equipment, gross | 2,447 | 2,425 | NaN | NaN |
| Less accumulated depreciation | 272 | 267 | NaN | NaN |
| Property and equipment, net | 2,175 | 2,158 | 20 | 37 |
| Operating lease right-of-use assets | 2,895 | 1,584 | 488 | 729 |
| Intangible assets, net | 2,609 | 2,650 | 22 | 26 |
| Other assets | 358 | 360 | 472 | 535 |
| Total assets | 24,787 | 28,564 | 15,415 | 20,142 |
| Accounts payable-Nonrelated Party | 3,634 | 1,855 | 3,639 | 4,268 |
| Accounts payable-Related Party | 1,315 | 4,811 | 2,054 | 670 |
| Operating lease liabilities | 506 | 332 | 307 | 443 |
| Advance from stockholders | NaN | NaN | NaN | 8,500 |
| Accrued expenses and other current liabilities | 5,468 | 4,897 | 6,553 | 5,806 |
| Total current liabilities | 10,923 | 11,895 | 12,553 | 19,687 |
| Convertible notes payable, net | 4,719 | 4,589 | 4,462 | 4,338 |
| Warrant liabilities | 570 | 351 | 833 | 548 |
| Operating lease liabilities, non-current | 2,499 | 1,240 | 136 | 223 |
| Other liabilities | 6 | 9 | 12 | 14 |
| Total liabilities | 18,717 | 18,084 | 17,996 | 24,810 |
| Preferred stock | NaN | 0 | 0 | NaN |
| Preferred stock-Series B2Preferred Stock | NaN | NaN | 0 | NaN |
| Preferred stock-Series B3Preferred Stock | NaN | NaN | 0 | NaN |
| Preferred stock-Series CConvertible Preferred Stock | NaN | NaN | 0 | NaN |
| Preferred stock-Series DConvertible Preferred Stock | NaN | NaN | 0 | NaN |
| Common stock, 0.001 par value, 70,000,000 shares authorized 11,873,323 and 11,648,323 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 12 | 12 | 12 | 9 |
| Additional paid-in capital | 138,755 | 138,413 | 130,992 | 122,259 |
| Accumulated deficit | -132,697 | -127,945 | -133,585 | -126,936 |
| Total stockholders equity | 6,070 | 10,480 | -2,581 | -4,668 |
| Total liabilities and stockholders equity | 24,787 | 28,564 | 15,415 | 20,142 |